DigiKnowItNews: Teen 多媒体教育网站对青少年儿科临床试验认知的效果:随机对照试验研究方案
本研究为平行组随机对照优效性试验,评估 DigiKnowItNews: Teen 多媒体教育网站对改善青少年及家长临床试验参与相关因素的效果。符合条件的 12 至 17 岁青少年与家长配对将随机分配至干预组或等待名单对照组,主要结局包括临床试验知识、态度与信念、自我效能、参与意愿、程序性恐惧及亲子沟通质量。
要点
- DigiKnowItNews: Teen 是面向青少年儿科临床试验教育的多媒体网站。
- 研究采用平行组随机对照优效性设计,干预组在线浏览内容 1 周。
- 主要结局涵盖知识、态度、自我效能、参与意愿、恐惧及沟通质量。
核心结论
- 该试验将评估 DigiKnowItNews: Teen 教育网站对青少年儿科临床试验参与相关因素的效果。
- 若发现有效,青少年及其家长可使用该网站辅助临床试验参与决策,临床研究研究者也可用于招募工作。
研究设计与样本
- 平行组随机对照优效性试验,评估 DigiKnowItNews: Teen 对改善青少年及家长临床试验参与相关因素的有效性。
- 符合条件的 12 至 17 岁青少年与家长配对随机分配至干预组或等待名单对照组。
- 所有参与者完成前测和后测问卷,干预组获得 1 周时间浏览 DigiKnowItNews: Teen 内容。
- 等待名单对照组在 study completion 后可选择浏览 DigiKnowItNews: Teen。
关键数值与推荐
- 主要结局为临床研究知识、对儿科临床试验的态度与信念、参与相关决策的自我效能、参与未来临床试验的意愿、程序性恐惧及亲子沟通质量。
- 同时收集对 DigiKnowItNews: Teen 的总体反馈和满意度。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pediatric research is crucial for the development of new scientific advancements, treatments, and therapies for adolescents. Yet relatively few pediatric clinical trials are conducted due to barriers to successful recruitment and retention, including knowledge and attitudes about clinical trials. Adolescents tend to experience greater autonomy to make decisions and have expressed interest in being part of the decision to participate in clinical trials. Increasing knowledge, positive attitudes, and self-efficacy related to clinical trials could positively impact the decision to participate in a pediatric clinical trial. However, there are currently few interactive, developmentally appropriate, web-based resources available to educate adolescents about clinical trials. DigiKnowItNews: Teen was created as a multimedia educational website to address the relatively low levels of enrollment in pediatric clinical trials and need for information to empower adolescents to make decisions about participating in clinical trials. METHODS: This is a parallel group randomized controlled superiority trial to test the effectiveness of DigiKnowItNews: Teen, for improving factors related to clinical trial participation among adolescent and parents. Eligible parent-adolescent (ages 12 to 17 years) pairs will be randomly assigned to one of two conditions: intervention or wait-list control. All participants will complete pre- and post-test questionnaires and participants assigned to the intervention will receive access to review the DigiKnowItNews: Teen content for 1 week. Wait-list control participants will have the option to review DigiKnowItNews: Teen after study completion. The primary outcomes are knowledge about clinical research, attitudes, and beliefs toward pediatric clinical trials, self-efficacy for making decisions related to clinical trial participation, willingness to participate in a future clinical trial, procedural fears, and parent-adolescent communication quality. Overall feedback and satisfaction related to DigiKnowItNews: Teen will also be collected. DISCUSSION: The trial will evaluate the effectiveness of DigiKnowIt News: Teen, an educational website about pediatric clinical trials for adolescents. If found effective in promoting factors related to future pediatric clinical trial participation, DigiKnowIt News: Teen could be used by adolescents, along with their parents, as they make the decision to participate in a clinical trial. Clinical trial researchers can also use DigiKnowIt News: Teen to aid their participant recruitment efforts. TRIAL REGISTRATION: ClinicalTrials.gov NCT05714943. Registered on 02/03/2023.
引用
- Parker AE, Scull TM, Kennedy KL, et al. Efficacy of DigiKnowItNews: Teen, a multimedia educational website for adolescents about pediatric clinical trials: study protocol for a randomized controlled trial. Trials. 2023. PMID: 37391773. doi:10.1186/s13063-023-07464-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。